SEC Company Response from NANOVIRICIDES, INC. (NNVC) (CIK 0001379006) (NNVC) — Apr 9, 2008
NANOVIRICIDES, INC. (NNVC) (CIK 0001379006)
Date: April 9, 2008 · CIK: 0001379006 · Accession: 0001140361-08-009173
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-148471
Letter
VIA EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Attention: NanoViricides, Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed on March 24, 2008 File No. 333-148471
Dear Mr. Riedler:
Please be advised that the undersigned is the duly elected Chief Executive Officer of NanoViricides, Inc. (the "Registrant"). Having been advised that the Commission has no further comments to the Registrant's Form S-1 Registration Statement, the Registrant hereby requests acceleration of the effective date of the Registration Statement to Friday, April 11, 2008 at 9:30 a.m., or as soon thereafter as practicable.
The Registrant is in receipt of your comment letter of March 31, 2008, as it relates to the Registrant’s Form S-1 filing. In accordance therewith, the Registrant acknowledges that staff comments or changes in response to staff comments in the proposed disclosure in the registration statement do not foreclose the Commission from taking any action with respect to the filing. The Registrant also acknowledges that the adequacy and accuracy of the disclosure in the above-referenced filing is the responsibility of the Registrant. The Registrant represents to the Commission that staff comments will not be asserted as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
Should you have any questions in regard to this correspondence or any other matter relating to this Registrant’s filing, please do not hesitate to contact me.
Very
truly yours,
/s/ Eugene Seymour
Show Raw Text
CORRESP
1
filename1.htm
corresp.htm
Nanotechnology-Enabled
Targeted Viricides”
A
Publicly Traded Company, “NNVC”
www.nanoviricides.com
April
8, 2008
VIA
EDGAR AND OVERNIGHT DELIVERY
United
States Securities and Exchange Commission
Mail Stop
6010
Washington,
D.C. 20549
Attention:
Jeffrey
P. Riedler,
Assistant
Director
Re:
NanoViricides,
Inc.
Amendment
No. 1 to Registration Statement on Form S-1
Filed on
March 24, 2008
File No.
333-148471
Dear Mr.
Riedler:
Please be
advised that the undersigned is the duly elected Chief Executive Officer of
NanoViricides, Inc. (the "Registrant"). Having been advised that the
Commission has no further comments to the Registrant's Form S-1 Registration
Statement, the Registrant hereby requests acceleration of the effective date of
the Registration Statement to Friday, April 11, 2008 at 9:30 a.m., or as soon
thereafter as practicable.
The
Registrant is in receipt of your comment letter of March 31, 2008, as it relates
to the Registrant’s Form S-1 filing. In accordance therewith, the
Registrant acknowledges that staff comments or changes in response to staff
comments in the proposed disclosure in the registration statement do not
foreclose the Commission from taking any action with respect to the filing. The
Registrant also acknowledges that the adequacy and accuracy of the disclosure in
the above-referenced filing is the responsibility of the
Registrant. The Registrant represents to the Commission that staff
comments will not be asserted as a defense in any proceeding initiated by the
Commission or any person under the federal securities laws of the United
States.
Should
you have any questions in regard to this correspondence or any other matter
relating to this Registrant’s filing, please do not hesitate to contact
me.
Very
truly yours,
/s/ Eugene Seymour
Eugene
Seymour, MD MPH
135 Wood
Street, Ste. 205, West Haven, CT 06516. Tel./Fax:
203-937-6137.